Solid Tumors

Solid Tumors

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

2 Clinical Trials
Solid Tumors II Active
nct/study# PTX-001-004

A Phase 2 Study Of The Safety and Tolerability of Sargramostim Added To Standard Of Care Ipilimumab Containing Checkpoint Inhibitor Therapy In Patients With Solid Tumors

Learn More
Solid Tumors I Active
nct/study# NCT04887194 / 516-010

A two-cohort, Two-part, Phase 1, Multicenter, Open-label, Fixed-sequence, Drug-Drug Interaction and QTc Assessments of Sitravatinib Followed by Combination Treatment with Nivolumab in Patients with Advanced Solid Malignancies.

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.